or
forgot password

Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis


N/A
21 Years
90 Years
Open (Enrolling)
Female
Breast Cancer

Thank you

Trial Information

Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis


Inclusion Criteria:



1. A female older than 21 years of age,

2. Have suspicious imaging findings suggesting a possibility of breast cancer, or
biopsy-proven breast cancer.

Exclusion Criteria:

1. Pregnant,

2. Unwilling to give informed consent,

3. Have implanted prosthetic heart valves, pacemaker, neuro-stimulation devices,
surgical clips (hemostatic clips) or other metallic implants,

4. Have engaged in occupations or activities which may cause accidental lodging of
ferromagnetic materials, or have imbedded metal fragments from military activities,

5. Have received orthodontic work involving ferromagnetic materials,

6. Claustrophobic,

7. Have had allergic response to contrast agents (such as iodine or gadolinium)
previously,

8. Have known history of severe renal insufficiency, asthma, allergic conditions, sickle
cell anemia, chronic hemolytic anemia, and gastrointestinal disorders.

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

To prove that combined optical/MRI imaging system can enhance the diagnostic specificity compared to that using MRI alone.

Outcome Time Frame:

at completion of this study

Safety Issue:

No

Principal Investigator

Min-Ying Su, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of California, Irvine

Authority:

United States: Institutional Review Board

Study ID:

UCI-HS-2006-5162

NCT ID:

NCT00610467

Start Date:

October 2006

Completion Date:

Related Keywords:

  • Breast Cancer
  • Breast Neoplasms

Name

Location

Center for Functional Onco-Imaging, University of California Irvine, California  92697